Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Immediate results and long term follow-up. A 7-year experience;Miocardiopatía hipertrófica obstructiva y estimulación secuencial auriculoventricular. Resultados agudos y seguimiento a largo plazo. Siete años de experiencia

Revista Espanola de Cardiologia

Volumn 53, Issue 8, 2000, Pages 1028-1039

  Tascón, Juan C ^a   Albarrán, Agustín ^a   Hernández, Felipe ^a   Alonso, Manuel ^a   Andreu, Javier ^a   Coma, Raúl ^a   Rodríguez, Jesús ^a   Hernández, Pedro ^a   Lázaro, María ^a   Gascueña, Raúl ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMEGALY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FUNCTION; HEART PACING; HEART VENTRICLE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FUNCTION; CARDIAC PACING, ARTIFICIAL; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED;

EID: 0034243722     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(00)75206-7     Document Type: Article

References (90)

1. Braunwald E, Lambrew CT, Rockoff SD, Ross J, Morrow AG. Idiopathic hypertrophic subaortic stenosis: a description of the disease based upon an analysis of 64 patients. Circulation 1964; 29-30 (Supl 4): 3-119.
2. Maron BJ. Hypertrophic cardiomyopathy. Curr Probl Cardiol 1993; 28: 639-704.
3. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-789 y 844-852.
4. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985; 53: 412-416.
5. Rollick C. Disopyramide in hypertrophic cardiomyopathy II. Non-invasive assessment after oral administration. Am J Cardiol 1988; 62: 1252-1255.
6. Seiler C, Hess OM, Schoenbeck M, Turina J, Jenni R, Turina M et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 1991; 17: 634-642.
7. McIntosh CL, Maron BJ. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 1988; 78: 487-494.
8. Krajcer Z, Leachman RD, Cooley DA, Coronado R. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. Circulation 1989; 80 (Supl 1): 57-64.
9. Cooley DA, Wukasch DC, Leachman RD. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis: results in 27 patients. J Cardiovasc Surg 1976; 17: 380-387.
10. Mohr R, Schaff HV, Danielson GK, Puga FJ, Pluth JR, Tajik AJ. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg 1988; 97: 666-674.
11. Beahrs MM, Tajik AJ, Seward JB, Giuliani ER, McGoon DC. Hypertrophic obstructive cardiomyopathy: ten-to 21-year follow-up after partial septal myectomy. Am J Cardiol 1983; 51: 1160-1166.
12. McCully RB. Nisimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996: 94: 467-471.
13. Brunner La Schönbeck MH, Rocca HP, Vogt PR, Lachat ML, Jenni R, Hess OM et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg 1998; 65: 1207-1214.
14. Delahaye F, Jegaden O, de Gevigney G, Genoud JL, Perinetti M, Montagna P et al. Postoperative and long-term prognosis of myotomy-myectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement. Eur Heart J 1993; 14: 1229-1237.
15. Schulte HD, Bircks WS, Loesse B, Godehardt EA, Schwartzkoptf B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg 1993; 106: 709-717.
16. Ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst SM, Vermeulen FE, Jaarsma W. Hypertongphic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy. Circulation 1994; 90: 1781-1785.
17. Torre de la JM, Sánchez N, Riesco F, Ruiz B, Ochoteco A, Zueco J et al. Inducción de infarto septal como alternativa terapéutica en la miocardiopatía hipertrófica obstructiva: nuevas observaciones a propósito de un case. Rev Esp Cardiol 1999; 52: 339-342.
18. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252-258.
19. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Veraqni MS et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998; 17: 1750-1755.
20. Kim JJ, Lee CW, Park SW, Hong MK, Lim HY, Song JK et al. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1999; 83: 1220-1223.
21. Gietzen FH, Leuner ChJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 20: 1342-1354.
22. Kern MJ, Rajjoub H, Bach R. Hemodynamic rounds series II. Hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy Cathet Cardiovasc Diagn 1999; 47: 221-228.
23. Hassenstein P, Storch HH, Schmitz W. Erfahrungen mit der schrittmacher dauerbehandlung bei patienten mit obstruktiver kardiomyopathie. Thoraxchirurgie 1975; 23: 496-498.
24. Duport G, Valeix B, Lefevre J, Nebunu J-C, Bouleau J-M, Garcia-Duport M et al. Intérêt de la stimulation ventriculaire droite permanente dans la cardiomyopathie obstructive. Nouv Presse Med 1978: 32 2868-2869.
25. Gardiner P, Gold RG, Willians DO. Beneficial effects of acute and chronic atrially triggered ventricular pacing (ATVP) in hypertrophic obstructive cardiomyopathy [resumen]. Pace 1983; 6: A38.
26. Duck HJ, Hutschenreiter W, Pankau H, Trenckmann H. Vorhofsynchrone ventrikelstimulation mit verkürzter a.v. Verzögerungszeit als therapieprinzip der hypertrophischen obstruktiven kardiomyopathie. Z Gesamte Inn Med 1984; 39: 437-447.
27. Erwin J, McWilliams E, Gearty G, Maurer B. Haemodynamic assessment of dual chamber pacing in hypertrophic cardiomyopathy using radionuclide ventriculography [resumen]. Br Heart J 1986; 55: 507.
28. McDonald K, McWilliams E, O'Keeffe B, Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988; 9: 893-898.
29. McDonald K, O'Sullivan JJ, King G, Conroy R, Maurer B. Dual chamber pacing improves ventricular filling in patients with hypertrophic cardiomyopathy [resumen]. Eur Heart J 1989; 10 (Supl): 401.
30. Ovadia M, Clyne C, Tripodi D, Fananapazir L. Dual chamber permanent pacing is an alternative to surgery in hypertrophic cardiomyopathy with severe left ventricular outflow obstruction [resumen]. Circulation 1990; 82: 333.
31. McDonald KM, Maurer B. Permanent pacing as treatment for hypertrophic cardiomyopathy. Am J Cardiol 1991; 68: 108-110.
32. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992: 85: 2149-2161.
33. Tascón J, Albarrán A, Pérez-Carasa M, Andreu J. Rodríguez J, Coma R et al. Tratamiento de la miocardiopatía hipertrófica obstructiva refractaria al tratamiento médico con estimulación DDD. Rev Esp Cardiol 1994; 47: 294-302.
34. Albarrán A, Tascón J, Perez-Carasa M, Lombera F, Andreu J, Alonso M et al. Mejoría de la función diastólica ventricular en la miocardiopatía hipertrófica obstructiva tratada con estimulación aurículo-ventricular [resumen]. Rev Esp Cardiol 1994; 47 (Supl 2): 2742.
35. Fananapazir L, Epstein N, Curiel R, Panza J, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-2742.
36. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339: 1318-1323.
37. Blanch P, Soto A, Tornos P, Bosch R, Evangelista A, Soler J. Marcapasos VVI en el tratamiento de la miocardiopatía hipertrófica obstructiva en fibrilación auricular. Rev Esp Cardiol 1993; 46: 455-457.
38. Tascón J, Albarrán A, Alonso M, Andreu J, Lombera F, Escribano P et al. Respuesta hemodinámica inmediata a la estimulación bicameral en la miocardiopatía hipertrófica obstructiva severa. Rev Esp Cardiol 1996; 49: 815-822.
39. Tascón J, Albarrán A, Alonso M, Andreu J, Hernández F, Sánchez V et al. Enfoque terapéutico en la miocardiopatía hipertrófica obstructiva severa con enfermedad coronaria multivaso. Rev Esp Cardiol 1999; 52: 343-347.
40. Glikson M, Hayes DL, Nishimura RA. Newer clinical applications of pacing. J Cardiovasc Electrophys 1997; 8: 1190-1203.
41. Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997; 18: 1249-1256.
42. Fannanapcir L, McArcavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol 1998; 31: 259-264.
43. Nisimura RA, Trusty RN,. Hayes DL, Ilstrup DM, Larson DR, Hayes SN et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435-441.
44. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1996; 27: 421-430.
45. Betocchi S, Losi MA, Piscione F, Boccalatte M, Pace L, Golino P et al. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol 1996; 77: 498-502.
46. Nishimura RA, Danielson GK. Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its come? [editorial]. Br Heart J 1993; 70: 301-303.
47. Maron BJ, Nishismura RA, McKenna WJ, Rakwski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999; 99: 2927-2933.
48. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 2: 426-440.
49. Takenaka K, Dabestani A, Gardin JM, Russel D, Clark S, Allfie A et al. Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Duppler echocardiographic study. J Am Coll Cardiol 1986; 7: 1263-1271.
50. DeMaria AN, Wiisenbaugh T. Identification and treatment of diastolic dysfunction: role of transmitral Duppler recordings. J Am Coll Cardiol 1987; 5: 1106-1107.
51. Spirito P, Maron BJ, Chiarella F, Belloti P, Tramarin R, Pozzoli M et al. Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation 1985; 72: 310-316.
52. Wigle ED, Rakowsk H, Kimball BP, Williams WG. Hypertrophic cardiomyopaty. Clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
53. Myreng Y, Smisth O. Assessment of left ventricular relaxation by duppler echocardiography. Comparison of isovolumic relaxation time and transmitral flow velocities with time constant isovolumic relaxation. Circulation 1990; 81: 260-266.
54. Nihoyannopoulos P, Karatasakis G, Frenneaux M, MaKenna WJ, Oakley C. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992; 19: 536-540.
55. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrosek DG, Labovitz AJ. Left ventricular diastolic function: comparison of pulsed Doppler echocardiographic and hemodynamic index in subject with and without coronary artery disease. J Am Coll Cardiol 1989; 13: 327-336.
56. Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol 1988; 11: 157-168.
57. Nishimura RA, Housmans PR, Hatle LK, Tajick AJ. Subject review. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part I. Physiologic and pathophysiologic features. Mayo Clin Proc 1989; 64: 71-81.
58. Nishimura RA, Abel MD, Hatle LK, Tajick AJ. Subject review. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical Studies. Mayo Clin Proc 1989; 64: 181-204.
59. Roudaut R, Gosse Ph, Dallocchio M. Étude de la diastole ventriculaire par écho-Doppler cardiaque. Arch Mal Coeur 1988; 81: 1535-1542.
60. Shah PM, Pai RG. Diastolic heart failure. Curr Probl Cardiol 1992; 17: 783-845.
61. Spirito P, Maron B, Bonow R. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol 1986; 7: 518-526.
62. Rokey R, Kuo LC, Zoghbi WA, Limacher MC, Quinones MA. Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation 1985; 71: 543-550.
63. Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertophic cardiomyopathy. J Am Coll Cardiol 1987; 10: 733-742.
64. Bryg RJ, Pearson AC, Williams GA, Labovitz AJ. Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 1987; 59: 925-931.
65. Friedman BJ, Drinkovic N, Miles H, Shin WJ, Mazzoleni A, DeMaria AN. Assessment of left ventricular diastolic function: comparison of duppler and gated blood pool scintigraphy. J Am Coll Cardiol 1986; 8: 1348-1354.
66. Candela H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968; 75: 315-334.
67. Wilson WS, Criley JM, Ross RS. Dynamics of left ventricular emptyins in hypertrophic subaortic stenosis: a cineangiographic and hemodynamic study. Am Heart J 1967; 73: 4-16.
68. Sasson Z, Henderson M, Wilansky S, Rakowski H, Wigle ED. Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13: 1275-1279.
69. Sugrue DD, Mckenna WJ, Dickie S, Myers MJ, Lavender JP, Oakley CM et al. Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyop. Assessment with radionuclide cineangiography. Br Heart J 1984; 52: 602-609.
70. Bonow RO. Left ventricular ejection dynamics and outflow obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13: 1280-1282.
71. Wilson WS, Criley JM, Ross RS. Dinamics of left ventricular emptyins in hypertrophic subaortic stenosis: a cineangiographic and hemodynamic study. Am Heart J 1967; 73: 4-16.
72. Adelman A, Mc Loughlin J, Marquis Y, Auger P, Wigle ED. Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol 1969; 24: 689-697.
73. Lardani H, Serrano J, Villamil R. Hemodynamics and coronary angiography in idiopatic hypertrophic subaortic stenosis. Am J Cardiol 1978; 41: 476-481.
74. Hammermeister KE, Warbasse JR. The rate of change of left ventricular volume in man. Circulation 1974; 49: 739-747.
75. Mancini GBJ, Slutky RA, Morris SL, Bhargave V, Ashburn WL, Higgins CB. Radionuclide analysis of peak filling rate, filling fraction and time to peak filling rate. Am J Cardiol 1983; 51: 43-51.
76. Weissler AM, Harris WS, Schoenfeld CD. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 1969; 23: 577-599.
77. Garrard CL, Weissler AM, Dodge HT. The relationship of alterations in systolic time intervals to ejection fraction in patients with cardiac disease. Circulation 1970; 42: 455-462.
78. Maron BJ, Gottdiner JS, Arce J, Rosing DR, Wesley YE, Epstein SE. Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Duppler echocardiography. J Am Coll Cardiol 1985; 6: 1-8.
79. Pollick C, Rakowski H, Wigle ED. Muscular subaortic stenosis: quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 1984; 69: 43-49.
80. Pollick C, Morgan CD, Gilbert BW, Rakowki H, Wigle ED. Muscular subaortic stenosis: The temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient. Circulation 1982,66: 1087-1094.
81. Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992; 85: 1651-1660.
82. Klues HG, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 1991; 84: 1188-1197.
83. Brutsaert DL, Rademaker FE, Stanislas U. Triple control of relaxation: implications in cardiac disease. Circulation 1984; 69: 190-196.
84. Wigle ED, Chrysohou A, Bigelow W. Results of ventriculomyolomy in muscular subaortic stenosis. Am J Cardiol 1963; 11: 572-586.
85. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984; 69: 855-865.
86. Murakami T, Otto M, Hess OM, Gage JE, Grimm J, Krayenbuehl HP. Diastolic filling dynamics in patients with aortic stenosis. Circulation 1986; 73: 1162-1174.
87. Kennedy JW, Doces J, Stewart DK. Left ventricular function before and following aortic valve replacement. Circulation 1977; 56: 944-950.
88. Cannon III RO, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE. Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 1989; 79: 766-775.
89. a ed.). Buenos Aires: Ed. Panamericana, 1991; 940-965.
90. Gilligan DM, Nihoyannopoulos P, Chan WL, Oakley C. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation 1992; 85: 2140-2148.